Lung Cancers Withdrawn Phase 1 / 2 Trials for Onartuzumab (DB11746)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02044601Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT)Treatment